Form 4: BioLargo CFO Receives Option Grant to Replace Expired Compensation

BioLargo's CFO, Charles K. Dargan, was granted an option to purchase 700,000 shares of common stock to replace a previously expired option.

Summary

• Charles K. Dargan, CFO of BioLargo, Inc., filed a Form 4 on June 25, 2024, reporting a transaction.
• On June 23, 2024, Dargan was granted an option to purchase 700,000 shares of BioLargo's common stock at an exercise price of $0.27.
• This option replaces a previous option for 300,000 shares that expired unexercised due to a discrepancy between the original exercise price and the current stock price.
• The original option was granted approximately 10 years ago as compensation for services to the Issuer.
• Following this transaction, Dargan beneficially owns 4,325,786 shares.
• John R. Browning, as attorney-in-fact, signed the report on behalf of Dargan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The option grant is a routine part of executive compensation, indicating stability and alignment of interests. The replacement of an expired option is a standard practice.

Positives

• The grant of the option suggests continued confidence in the CFO's role and contribution to the company.
• The replacement of the expired option ensures that the CFO remains incentivized through equity ownership.

Industry Context

Option grants to executives are a common practice in publicly traded companies to align management's interests with those of shareholders and incentivize performance.

Comparison to Industry Standards

• Executive compensation packages, including stock options, vary widely across industries and company sizes.
• Comparing BioLargo's executive compensation to similar companies in the environmental technology sector would provide a better benchmark.
• Companies like Xylem, Danaher, and Veolia Environnement are much larger but operate in related fields and can provide context for compensation structures.

Stakeholder Impact

• The option grant aligns the CFO's interests with those of shareholders, potentially driving long-term value creation.
• Employees may view the option grant as a positive sign of the company's commitment to its leadership.

Key Dates